UPDATE: Mizuho Securities Maintains Magenta Therapeutics (MGTA) at Buy (correction)
Tweet Send to a Friend
(Updated - January 28, 2021 6:08 AM EST)
Mizuho Securities analyst Defei Yang maintains ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Mizuho Securities analyst Defei Yang maintains ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
